FIVE PRIME THERAPEUTICS INC Human Resources Contracts & Agreements
40 Contracts & Agreements
- Bonus & Incentive Agreements (13 contracts)
- Compensation Agreements (1)
- Consulting Agreements (4)
- Retention Agreements (4)
- Separation Agreements (1)
- Severance Agreements (17)
- Non-Employee Director Compensation Policy, effective November 21, 2019 (Filed With SEC on February 27, 2020)
- Executive Severance Benefit Plan and Summary Plan Description, effective November 20, 2019 (Filed With SEC on February 27, 2020)
- Retention Letter Agreement by and between the company and Francis Sarena, dated as of January 15, 2020 (Filed With SEC on February 27, 2020)
- Retention Letter Agreement by and between the company and Helen Collins, dated as of January 15, 2020 (Filed With SEC on February 27, 2020)
- Retention Letter Agreement by and between the company and David V. Smith, dated as of January 15, 2020 (Filed With SEC on February 27, 2020)
- Separation Agreement by and between the company and Aron M. Knickerbocker, dated as of September 19, 2019 (Filed With SEC on November 6, 2019)
- Consulting Agreement by and between the company and Lewis T. Williams, effective as of April 1, 2019 (Filed With SEC on May 9, 2019)
- Amendment No. 1 to the Confidential Consulting Agreement by and between the company and FLG Partners, LLC, dated as of October 13, 2018.v (Filed With SEC on February 26, 2019)
- Executive Severance Benefits Agreement by and between the company and David V. Smith, dated as of November 26, 2018 (Filed With SEC on February 26, 2019)
- Executive Severance Benefits Agreement by and between the company and Bryan Irving, dated as of September 5, 2017 (Filed With SEC on February 26, 2019)
- Confidential Consulting Agreement, by and between the company and FLG Partners, LLC, effective as of April 13, 2018 (Filed With SEC on May 8, 2018)
- Consulting Agreement by and between the company and Marc Belsky effective as of April 7, 2018 (Filed With SEC on May 8, 2018)
- Annual Bonus Plan, effective January 1, 2018 (Filed With SEC on February 27, 2018)
- Executive Severance Benefits Agreement by and between the company and Helen Collins, dated as of March 20, 2017 (Filed With SEC on February 27, 2018)
- Amendment No. 1 to the 2013 Omnibus Incentive Plan (Filed With SEC on November 6, 2017)
- Amendment No. 2 to the Executive Severance Benefits Agreement by and between the Company and Aron Knickerbocker, dated as of October 18, 2017 (Filed With SEC on November 6, 2017)
- Annual Bonus Plan (Filed With SEC on November 6, 2017)
- Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Restricted Stock Agreement (Filed With SEC on February 24, 2017)
- Executive Severance Benefits Agreement (Filed With SEC on February 24, 2017)
- Amendment No. 1 to the Executive Severance Benefits Agreement (Filed With SEC on February 24, 2017)
- Executive Severance Benefits Agreement (Filed With SEC on February 24, 2017)
- Executive Transition and Severance Benefits Agreement (Filed With SEC on March 11, 2016)
- Retention Award Agreement (Filed With SEC on May 4, 2015)
- Amendment No. 1 to the Executive Severance Benefits Agreement (Filed With SEC on January 22, 2014)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on January 22, 2014)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on January 22, 2014)
- Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Restricted Stock Agreement (Filed With SEC on January 22, 2014)
- FIVE PRIME THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2002 EQUITY INCENTIVE PLAN) (Filed With SEC on July 26, 2013)
- Amendment No. 1 to the Executive Severance BenefitsAgreement (Filed With SEC on July 26, 2013)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on July 26, 2013)
- Amendment No. 1 to the Executive Severance BenefitsAgreement (Filed With SEC on July 26, 2013)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on July 26, 2013)
- 2007 EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on July 26, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN NON-QUALIFIED OPTION AGREEMENT (Filed With SEC on July 26, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on July 26, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on July 26, 2013)
- Option Agreement (Incentive Stock Option or Nonstatutory Stock Option) Five Prime Therapeutics, Inc. 2010 Equity Incentive Plan (Filed With SEC on July 26, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:OCTOBER 28, 2010 APPROVED BY THESTOCKHOLDERS: DECEMBER 9, 2010 TERMINATION DATE:OCTOBER... (Filed With SEC on July 26, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2002 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCKOPTION) (Filed With SEC on July 26, 2013)
- FIVE PRIME THERAPEUTICS, INC. 2002 EQUITY INCENTIVE PLAN ADOPTED: MARCH 14, 2002 APPROVED BY STOCKHOLDERS: MARCH 14, 2002 AMENDED AND RESTATED BY THE BOARD OF DIRECTORS ONMAY 21,... (Filed With SEC on July 26, 2013)
